1 / 13

Global Vaccine Market to be US$ 70 Billion by 2024

For more Info:<br><br>https://www.renub.com/global-vaccines-market-to-be-an-opportunity-of-more-than-us-60-billion-58-nd.php<br><br>According to Renub Research latest report on Vaccine industry Global Vaccine Market around the world would be US$ 70 Billion by the year 2024. Vaccine is considered as one of the best quality science across all streams pertinent in the field of Vaccinology. Vaccines are derived from the killed or inactivated pathogens, which are unable to cause any sickness to vaccinated people. When a person is vaccinated, it is impracticable for them to become sick with that particular disease. Early vaccination and the completion of complete vaccination schedule among the infants to their adulthood, helps reduce the prevalence of vaccine preventable diseases and its burden across the countries around the world.<br>

renubresearch
Download Presentation

Global Vaccine Market to be US$ 70 Billion by 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Category: Vaccines Market Research Report

  2. Global Vaccine Market and Forecast Analyst View: • Global Vaccine Market is projected to reach US$ 70 Billion by the year 2024. • GetFree Customization in this Report • Press Release Title: • Global Vaccine Market predicted to be US$ 70 Billion by 2024 • For more Info: • https://www.renub.com/global-vaccines-market-to-be-an-opportunity-of-more-than-us-60-billion-58-nd.php

  3. Global Vaccine Market predicted to be US$ 70 Billion by 2024 • Research Report Title: • Global Vaccine Market, People Vaccinated, Vaccines Administered, Immunization, By Disease [Influenza, Cervical Cancer, Zoster (Shingles), MMR (Measles, Mumps, and Rubella), Pneumonia, Meningitis, Hepatitis, Tap (Diphtheria, Tetanus, Pertussis), Haemophilusinfluenzae type B (Hib), Polio, Rotavirus, Varicella, Combination Vaccine, Travel & Miscellaneous Vaccine], By End User [Infants (Pediatric), & Adult], Companies (GlaxoSmithKline, Merck, Sanofi, Pfizer, & Others) • Access Full Research:  • https://www.renub.com/global-vaccines-market-and-forecast-14-vaccines-market-number-of-people-immunized-doses-of-vaccines-administered-1200-p.php • According to Renub Research latest report on Vaccine industry Global Vaccine Market around the world would be US$ 70 Billion by the year 2024. Vaccine is considered as one of the best quality science across all streams pertinent in the field of Vaccinology. Vaccines are derived from the killed or inactivated pathogens, which are unable to cause any sickness to vaccinated people.

  4. Global Vaccine Market predicted to be US$ 70 Billion by 2024 Today, vaccination has helped to reduce the global burden of a range of viral and bacterial diseases around the world. Vaccination against the particular disease not only limits the incidence of that disease, but it also minimizes the socioeconomic burden of that disease in the society. An appropriate rate of immunization can lead to the substantial blocking of transmission for several vaccine preventable diseases. Today, the world has witnessed the eradication of smallpox and is near to the elimination of polio from most countries across the world due to the role of immunization in controlling disease. List of some of the vaccine Preventable diseases include: •    Diphtheria •Pertussis (whooping cough)•    MMR •    Polio (poliomyelitis)•    Hib •    Influenza•    Hepatitis •    Pneumococcal infections•    Meningococcal disease •Varicella-zoster •    Human papillomavirus •    Tetanus•    Yellow fever •    Japanese encephalitis

  5. Global Vaccine Market predicted to be US$ 70 Billion by 2024

  6. Global Vaccine Market predicted to be US$ 70 Billion by 2024 How do Vaccines Work? Vaccines work is to prime one’s immune system against future attacks by a specific disease. There are vaccines that work against both bacterial and viral pathogens and disease causing agents. When a pathogen enters in the immunized person’s body, the person’s immune system generates antibodies to fight it off. Depending upon the strength of one’s immune response and how effectively the antibodies scrap off the pathogen, one may or may not get ill. Client can Purchase this Report in Sections from below link:  Access full Research: https://www.renub.com/global-vaccines-market-and-forecast-14-vaccines-market-number-of-people-immunized-doses-of-vaccines-administered-1200-p.php

  7. Global Vaccine Market is projected to reach US$ 70 Billion by the year 2024. When a person is vaccinated with whatever the version of a pathogen that vaccine contains, the vaccination isn’t so strong to make them sick, but it has enough for one’s immune system to develop resistance against the particular pathogen. As a result, the person gets future immunity against the disease without getting ill; if when exposed to the pathogen. Today, with increasing community awareness regarding the benefits of vaccines against vaccine preventable diseases, increasing government role in strengthening immunization programs and increasing funding from several governments and non-governments sectors certainly help boost Global Vaccines Market in the near future. 

  8. Table of Contents for Global Vaccine Market & Forecast Key Topics Covered 1.    Research Findings 2.    Global – Vaccines Market and Forecast 2.1    Adult Vaccines Market 2.2    Pediatric (Infant) Vaccines Market 3.    Global – Adult Vaccine vs. Pediatric Vaccine Market Share 4.    Global – Vaccines Market Share and Forecast 4.1    Adult Vaccines Market Share 4.2    Pediatric (Infant) Vaccines Market Share 5.    Global – Vaccinated People 5.1    Adult Immunized and Forecast 5.2    Vaccinated Infant (Pediatric) 6.    Global – Vaccinated People Share 6.1    Vaccinated Adult Share 6.2    Vaccinated Infant (Pediatric) Share

  9. Table of Contents for Global Vaccine Market & Forecast 7.    Global – Doses of Vaccines Administered and Forecast 7.1    Doses of Adult Vaccines Administered 7.2    Doses of Infant (Pediatric) Vaccines Administered 8.    Global – Doses of Vaccines Administered Share 8.1    Doses of Vaccines Administered to Adult Share8.2    Doses of Vaccines Administered to Infant (Pediatric) Share 9.    Global – Vaccine Companies Market Share and Forecast 10.    Disease wise – Vaccines Market and Forecast 10.1    Influenza 10.2    Cervical Cancer (HPV) 10.3    Zoster (Shingles) 10.4    MMR 10.5    Pneumococcal 10.6    Meningococcal 10.7    Hepatitis 10.8    TdaP and DTaP 10.9    Travel and Miscellaneous 10.10    HaemophilusInfluenzae Type B 10.11    Combos (Combination) 10.12    Polio 10.13    Rotavirus 10.14    Varicella

  10. Table of Contents for Global Vaccine Market & Forecast 11.    Disease wise – Numbers of Vaccinated People & Forecast 11.1    Influenza 11.2    Cervical Cancer (HPV) 11.3    Zoster (Shingles) 11.4    MMR 11.5    Pneumococcal 11.6    Meningococcal 11.7    Hepatitis 11.8    TdaP and DTaP 11.9    Hib (HaemophilusInfluenzae Type B) 11.10    Combos (Combination Vaccines) 11.11    Polio 11.12    Rotavirus 11.13    Varicella 12.    Disease wise – Doses of Vaccines Administered and Forecast 12.1 Influenza 12.2 Cervical Cancer (HPV) 12.3 Zoster (Shingles) 12.4 MMR 12.5 Pneumococcal 12.6 Meningococcal 12.7 Hepatitis 12.8 TdaP and DTaP 12.9 Hib (HaemophilusInfluenzae Type B) 12.10 Polio 12.11 Rotavirus 12.12 Varicella 13.    Disease wise - Immunization Profile 13.1    Immunization Coverage (%) in Infants 13.2    Global Immunization Profile 13.3    Regional Immunization Profile

  11. Table of Contents for Global Vaccine Market & Forecast 14.    Vaccines Key Players Sales and Forecast 14.1    GlaxoSmithKline, plc.’s Vaccines Sales 14.2    Merck & Co. Vaccines Sales 14.3    Sanofi Pasteur’s Vaccines Sales 14.4    Pfizer, Inc.’s Vaccines Sales 14.5    Global – Other Companies Vaccines Sales 15.    Vaccines – Products and Pipeline 15.1    GSK Vaccine Product Pipeline 15.2    Merck Vaccine Product Pipeline 15.3    Sanofi Vaccine Product Pipeline 15.4    Pfizer Vaccine Product Pipeline 16.    Top Mergers and Acquisitions in the Vaccine Industry 17.    Vaccines and Regulator’s Interventions 17.1    Making and Meeting Standards of Quality and Safety 17.2    Vaccine Funding

  12. Table of Contents for Global Vaccine Market & Forecast 18.    Vaccine Market Drivers 18.1    Inclusion in National Immunization Schedule 18.2    Growing Immunization Coverage for HPV Vaccines 18.3    Increase in Prevalence of Infectious Diseases 18.4    Global Immunization Vision and Strategy (GIVS) 18.5    GAVI Model Fuelling Vaccine Manufacturers 18.6    Increasing Vaccine Availability in United States 18.7    The Vaccine Safety Data link Project 18.8    The Vaccine Injury Compensation Program 18.9    Transforming of Vaccine Technologies 18.10    Global Vaccine Action Plan by WHO (2011 - 2020) 18.11    Continuous Focus on Effective Communication Strategies 19.    Vaccines Market Challenges 19.1    Hurdles to Optimal use of Licensed Vaccines 19.2    Complexity of Vaccine Development & Approval System Thwarts Product 19.3    Shortening the Timeline for Vaccine Development 19.4    Refusal/Resistance to Vaccination 19.5    Vaccine Shortages and Delays 19.6    Obstacles in Vaccine Research & Development 19.7    Barriers to New Entrants in the Vaccines Market

  13. GetFree Customization in this Report Vaccines Market Reports: https://www.renub.com/vaccines-12-c.php

More Related